Why the interest?
Skin rejuvenation research asks whether cell signaling can translate into a measurable clinical contribution. Topical preparations used after procedures such as microneedling are a particular focus. A useful assessment separates the preparation’s effect from the procedure itself.
Two examples from human studies
A 2023 study compared the two sides of the face in 28 participants: microneedling with an EV-containing solution versus microneedling with saline. Over the 12-week study, several wrinkle, elasticity, hydration and pigmentation measures favored the EV side.
A 2026 study in 60 adults evaluated adding topical EVs to radiofrequency microneedling. It reported a short-term incremental benefit signal; assessment was unblinded and follow-up lasted 12 weeks. These findings are promising, but do not establish durable results or equivalent effects across products.
What decision belongs in a consultation?
Start with the goal: uneven pigmentation, texture, scars and dryness are different concerns. Compare the proposed addition with established options in expected benefit, recovery time and cost. The study’s preparation, route and skin concern should match the proposal.
The absence of serious adverse events in a small topical study does not establish injection safety or risks over years. Consistent photography and predefined measurements help make individual outcomes more interpretable.